Non-aspirin NSAIDs linked with 30-60% reduced risk of Alzheimer's in early study results.
This article was originally published in The Tan Sheet
Executive Summary
NON-ASPIRIN NSAIDs LINKED TO 30-60% REDUCED RISK OF ALZHEIMER'S DISEASE in preliminary results of a Johns Hopkins University longitudinal study presented at the American Academy of Neurology annual meeting in San Francisco on March 28. In the study, acetaminophen and aspirin provided "no significant protection" against the illness, according to study presenters.